213 related articles for article (PubMed ID: 28744816)
1. ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.
Kumar A; Rani B; Sharma R; Kaur G; Prasad R; Bahl A; Khullar M
Mol Cell Biochem; 2018 Jan; 438(1-2):167-174. PubMed ID: 28744816
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system gene polymorphisms as potential modifiers of hypertrophic and dilated cardiomyopathy phenotypes.
Rani B; Kumar A; Bahl A; Sharma R; Prasad R; Khullar M
Mol Cell Biochem; 2017 Mar; 427(1-2):1-11. PubMed ID: 28120210
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.
Wang SX; Fu CY; Zou YB; Wang H; Shi Y; Xu XQ; Chen JZ; Song XD; Huan TJ; Hui RT
Chin Med J (Engl); 2008 Jan; 121(1):27-31. PubMed ID: 18208662
[TBL] [Abstract][Full Text] [Related]
4. Correction to: ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.
Kumar A; Rani B; Sharma R; Kaur G; Prasad R; Bahl A; Khullar M
Mol Cell Biochem; 2019 Jan; 450(1-2):209-210. PubMed ID: 30488312
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.
García-Honrubia A; Hernández-Romero D; Orenes-Piñero E; Romero-Aniorte AI; Climent V; García M; Garrigos-Gómez N; Moro C; Valdés M; Marín F
Eur J Clin Invest; 2016 Feb; 46(2):123-9. PubMed ID: 26608562
[TBL] [Abstract][Full Text] [Related]
6. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy.
Friedrich FW; Bausero P; Sun Y; Treszl A; Krämer E; Juhr D; Richard P; Wegscheider K; Schwartz K; Brito D; Arbustini E; Waldenström A; Isnard R; Komajda M; Eschenhagen T; Carrier L;
Eur Heart J; 2009 Jul; 30(13):1648-55. PubMed ID: 19429631
[TBL] [Abstract][Full Text] [Related]
7. Effect of rs4646994 polymorphism of angiotensin-converting enzyme on the risk of nonischemic cardiomyopathy.
Shen J; Qian X; Mei X; Yao J; Jiang H; Li K; Chen T; Jiang Y; Zhou Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750628
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamilial hypertrophic or dilated cardiomyopathy.
Yamada Y; Ichihara S; Fujimura T; Yokota M
Am J Hypertens; 1997 Aug; 10(8):921-8. PubMed ID: 9270088
[TBL] [Abstract][Full Text] [Related]
9. Impact of angiotensin I converting enzyme insertion/deletion polymorphisms on dilated cardiomyopathy and hypertrophic cardiomyopathy risk.
Yang J; Zhao Y; Hao P; Meng X; Dong M; Wang Y; Zhang Y; Zhang C
PLoS One; 2013; 8(5):e63309. PubMed ID: 23691019
[TBL] [Abstract][Full Text] [Related]
10. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
[TBL] [Abstract][Full Text] [Related]
11. Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy.
Puckelwartz MJ; Pesce LL; Dellefave-Castillo LM; Wheeler MT; Pottinger TD; Robinson AC; Kearns SD; Gacita AM; Schoppen ZJ; Pan W; Kim G; Wilcox JE; Anderson AS; Ashley EA; Day SM; Cappola T; Dorn GW; McNally EM
J Am Heart Assoc; 2021 Apr; 10(7):e019944. PubMed ID: 33764162
[TBL] [Abstract][Full Text] [Related]
12. Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
Waldmüller S; Erdmann J; Binner P; Gelbrich G; Pankuweit S; Geier C; Timmermann B; Haremza J; Perrot A; Scheer S; Wachter R; Schulze-Waltrup N; Dermintzoglou A; Schönberger J; Zeh W; Jurmann B; Brodherr T; Börgel J; Farr M; Milting H; Blankenfeldt W; Reinhardt R; Özcelik C; Osterziel KJ; Loeffler M; Maisch B; Regitz-Zagrosek V; Schunkert H; Scheffold T;
Eur J Heart Fail; 2011 Nov; 13(11):1185-92. PubMed ID: 21750094
[TBL] [Abstract][Full Text] [Related]
13. Association of AGTR1 and ACE2 gene polymorphisms with structural atrial fibrillation in a Chinese Han population.
Feng W; Sun L; Qu XF
Pharmazie; 2017 Jan; 72(1):17-21. PubMed ID: 29441892
[TBL] [Abstract][Full Text] [Related]
14. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Hernández-Romero D; Orenes-Piñero E; García-Honrubia A; Climent V; Romero-Aniorte AI; Martínez CM; García-Bautista M; Martínez M; Feliu E; González J; Cánovas S; Montero-Argudo JA; Valdés M; Marín F
J Intern Med; 2015 Jul; 278(1):50-8. PubMed ID: 25476756
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing identifies a novel mutation (c.333 + 2T > C) of TNNI3K in a Chinese family with dilated cardiomyopathy and cardiac conduction disease.
Fan LL; Huang H; Jin JY; Li JJ; Chen YQ; Zhao SP; Xiang R
Gene; 2018 Mar; 648():63-67. PubMed ID: 29355681
[TBL] [Abstract][Full Text] [Related]
18. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
[TBL] [Abstract][Full Text] [Related]
19. Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China.
Pan Y; Wang T; Li Y; Guan T; Lai Y; Shen Y; Zeyaweiding A; Maimaiti T; Li F; Zhao H; Liu C
Lipids Health Dis; 2018 Oct; 17(1):241. PubMed ID: 30342552
[TBL] [Abstract][Full Text] [Related]
20. TCAP gene is not a common cause of cardiomyopathy in Iranian patients.
Alaei Z; Zamani N; Rabbani B; Mahdieh N
Eur J Med Res; 2023 Sep; 28(1):376. PubMed ID: 37752589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
